Smith & Nephew acquires CartiHeal for $180 million upfront

Smith & Nephew agreed to buy CartiHeal for $180 million upfront, with up to $150 million in additional payments tied to financial performance. CartiHeal makes the Agili-C knee implant for cartilage regeneration.

“Smith & Nephew struck an agreement last week to buy CartiHeal for $180 million upfront to expand its range of sports medicine technologies.”medtechdive.com

• 1 source
• medtechdive.comSmith & Nephew inks $180M CartiHeal buyout, capitalizing on Bioventus turmoil to land knee implant | MedTech DiveNick Paul TaylorNov 27, 2023

Summarized from public sources; check the original articles before acting on it.